Get the Stockscreener App
32.17
2.28%
-0.815
Grail Inc stock is traded at $32.17, with a volume of 396.31K.
It is down -2.28% in the last 24 hours and up +80.41% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
See More
Previous Close:
$32.99
Open:
$33
24h Volume:
396.31K
Relative Volume:
0.40
Market Cap:
$1.11B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-0.5315
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
+6.47%
1M Performance:
+80.41%
6M Performance:
+82.97%
1Y Performance:
+0.00%
1-Day Range:
$31.01
$33.36
1-Week Range:
$27.50
$35.67
52-Week Range:
$12.33
$35.67
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
650-771-9796
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
32.15 | 1.11B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
570.75 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.34 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.55 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
457.91 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.47 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
Perigon Wealth Management LLC Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (GRAL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Grail (NASDAQ:GRAL) Stock Price Down 6.6%Here's What Happened - MarketBeat
Grail (NASDAQ:GRAL) Reaches New 12-Month HighWhat's Next? - MarketBeat
Grail, Inc. (NASDAQ:GRAL) Sees Large Increase in Short Interest - MarketBeat
Grail (NASDAQ:GRAL) Trading Up 8.2%What's Next? - MarketBeat
28,388 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Exchange Traded Concepts LLC - MarketBeat
Grail (NASDAQ:GRAL) Shares Up 8.2%Here's Why - MarketBeat
Grail (NASDAQ:GRAL) Sets New 52-Week HighHere's What Happened - MarketBeat
Slow Capital Inc. Invests $2.38 Million in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Dynatrace, Inc. (DT): Accelerating Growth with AI and Logs on Grail - Insider Monkey
Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - MSN
GRAIL, Inc. (NASDAQ:GRAL) institutional investors have had a good week as stock gains 49% - Simply Wall St
Grail's Stock Soars Amidst Cancer Screening BreakthroughsNews and Statistics - IndexBox, Inc.
Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week - Yahoo Finance
Grail (NASDAQ:GRAL) Sees Strong Trading VolumeHere's Why - MarketBeat
Wesbanco Bank Inc. Takes Position in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading Up 9.2%Here's What Happened - MarketBeat
Grail (NASDAQ:GRAL) Reaches New 1-Year HighTime to Buy? - MarketBeat
Why Grail (GRAL) Is Rallying for a Second Straight Day - MSN
Grail initiated at equal weight by Morgan Stanley - MSN
GRAIL: Cash Burn And Commercialization Timeline Are Problematic (NASDAQ:GRAL) - Seeking Alpha
Grail, Inc. Shares Soar 20% on Strong Growth ProjectionsNews and Statistics - IndexBox, Inc.
Grail (NASDAQ:GRAL) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Grail (NASDAQ:GRAL) Shares Up 9.2%Still a Buy? - MarketBeat
Objective long/short (GRAL) Report - Stock Traders Daily
Grail, Inc. (NASDAQ:GRAL) Short Interest Up 18.6% in December - MarketBeat
B & T Capital Management DBA Alpha Capital Management Acquires New Stake in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
US court strikes down FTC order against Illumina's purchase of Grail - AOL
Grail (NASDAQ:GRAL) Stock Price Down 4.4%What's Next? - MarketBeat
Arden Theatre Company Extends HOLY GRAIL OF MEMPHIS - BroadwayWorld
Grail 2024 revenue guidance range above consensus - MSN
Multi Cancer Early Detection Research Report 2025: Global Market to Reach $2.86 Billion by 2030, Growing at a CAGR of 17% with Liquid Biopsy Segment Leading - Yahoo Finance
180 Wealth Advisors LLC Takes $1.68 Million Position in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology - PR Newswire
GRAIL's Galleri Cancer Test Shows High Patient Satisfaction, Minimal Anxiety in Landmark Study - StockTitan
Trend Tracker for (GRAL) - Stock Traders Daily
Why a Roth IRA is the ‘holy grail’ retirement account—no matter your income - Yahoo Finance
Douglas Lane & Associates LLC Buys New Shares in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Liquid Biopsy Market Anticipated to Show Positive Growth - openPR
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.22%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):